Emmaus Life Sciences

Emmaus Medical, Inc. is a biopharmaceutical company dedicated to improving the lives of individuals with rare and orphan diseases, particularly through their flagship product, Endari, which is a treatment for sickle cell disease. The company actively engages in the discovery, development, and commercialization of innovative therapies, with plans to... target a broader range of conditions, including diverticulosis. Emmaus aims to cater to patients suffering from these significant health challenges, as well as healthcare providers and associations that support them. The company also emphasizes expanding its reach within the Middle East and North Africa regions, enhancing access to its treatments.Read More